Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorARAUJO, Luiz H
dc.contributor.authorFERREIRA, Carlos Gil
dc.contributor.authorBALDOTTO, Clarissa S.
dc.contributor.authorMATHIAS, Clarissa
dc.contributor.authorCASTRO JR., Gilberto
dc.contributor.authorCOUDRY, Renata
dc.date.accessioned2021-02-18T13:27:48Z
dc.date.available2021-02-18T13:27:48Z
dc.date.issued2020
dc.description.abstractThe objective of this review is to address the barriers limiting access to next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) for metastatic nonsquamous non-small cell lung cancer in Brazil and to propose its implementation in practice. A selected panel of lung cancer experts was provided with relevant prompts to address at a conference; a paper was then compiled on the topic. The authors propose specific and realistic recommendations for implementing access to ctDNA NGS. Further, the authors address all barriers and impediments mentioned within this review. There is a great need to increase ctDNA NGS for cancer care in Brazil. Adapting the current cancer testing framework is essential to expanding the use of this tool.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipAmericas Health Foundation (AHF)
dc.description.sponsorshipRocheRoche Holding
dc.identifier.citationFUTURE ONCOLOGY, v.17, n.2, p.205-214, 2020
dc.identifier.doi10.2217/fon-2020-0583
dc.identifier.eissn1744-8301
dc.identifier.issn1479-6694
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/39137
dc.language.isoeng
dc.publisherFUTURE MEDICINE LTDeng
dc.relation.ispartofFuture Oncology
dc.rightsopenAccesseng
dc.rights.holderCopyright FUTURE MEDICINE LTDeng
dc.subjectBrazileng
dc.subjectcirculating tumor DNAeng
dc.subjectmetastaticeng
dc.subjectnext-generation sequencingeng
dc.subjectNGSeng
dc.subjectnon-small cell lung cancereng
dc.subjectNSCLCeng
dc.subject.otherof-american-pathologistseng
dc.subject.othermutationseng
dc.subject.othervalidationeng
dc.subject.otherinhibitorseng
dc.subject.otherblockadeeng
dc.subject.otheroncologyeng
dc.subject.wosOncologyeng
dc.titleNext-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practiceeng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalARAUJO, Luiz H:Brazilian Natl Canc Inst, Rio De Janeiro, Brazil; COI Inst Res & Educ, Rio De Janeiro, Brazil
hcfmusp.author.externalFERREIRA, Carlos Gil:Oncoclin Inst Res & Educ, Rio De Janeiro, Brazil
hcfmusp.author.externalBALDOTTO, Clarissa S.:Inst DOr Res & Educ, Rio De Janeiro, Brazil
hcfmusp.author.externalMATHIAS, Clarissa:NOB Oncoclin, Salvador, BA, Brazil
hcfmusp.author.externalCOUDRY, Renata:United Hlth Grp Brazil, Sao Paulo, Brazil
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.description.beginpage205
hcfmusp.description.endpage214
hcfmusp.description.issue2
hcfmusp.description.volume17
hcfmusp.origemWOS
hcfmusp.origem.pubmed33052747
hcfmusp.origem.scopus2-s2.0-85099844817
hcfmusp.origem.wosWOS:000578231100001
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.reference[Anonymous], 2020, LUNG CANCeng
hcfmusp.relation.referenceAraujo LH, 2019, J BRAS EC SAUDE, V11, P221eng
hcfmusp.relation.referenceAraujo LH, 2018, J BRAS PNEUMOL, V44, P55, DOI [10.1590/S1806-37562017000000135, 10.1590/s1806-37562017000000135]eng
hcfmusp.relation.referenceCanon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1eng
hcfmusp.relation.referenceCollisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385eng
hcfmusp.relation.referenceCosta G, 2016, LUNG CANCER, V97, P66, DOI 10.1016/j.lungcan.2016.04.019eng
hcfmusp.relation.referenceFares Charlene M, 2019, Am Soc Clin Oncol Educ Book, V39, P147, DOI 10.1200/EDBK_240837eng
hcfmusp.relation.referenceFerreira CG, 2018, J THORAC ONCOL, V13, pS714, DOI 10.1016/j.jtho.2018.08.1183eng
hcfmusp.relation.referenceFrampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696eng
hcfmusp.relation.referenceGainor JF, 2016, CLIN CANCER RES, V22, P4585, DOI 10.1158/1078-0432.CCR-15-3101eng
hcfmusp.relation.referenceHallin J, 2020, CANCER DISCOV, V10, P54, DOI 10.1158/2159-8290.CD-19-1167eng
hcfmusp.relation.referenceHeitzer E, 2019, NAT REV GENET, V20, P71, DOI 10.1038/s41576-018-0071-5eng
hcfmusp.relation.referenceHirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8eng
hcfmusp.relation.referenceINCA - Instituto Nacional de Cancer, 2020, INC CANC BRAZeng
hcfmusp.relation.referenceINCA - Instituto Nacional de Cancer, 2019, CANC PULMeng
hcfmusp.relation.referenceLee CK, 2017, J THORAC ONCOL, V12, P403, DOI 10.1016/j.jtho.2016.10.007eng
hcfmusp.relation.referenceLindeman NI, 2018, J THORAC ONCOL, V13, P323, DOI 10.1016/j.jtho.2017.12.001eng
hcfmusp.relation.referenceLiu LP, 2018, GENE CHROMOSOME CANC, V57, P211, DOI 10.1002/gcc.22522eng
hcfmusp.relation.referenceMalta Deborah Carvalho, 2007, J. bras. pneumol., V33, P536, DOI 10.1590/S1806-37132007000500008eng
hcfmusp.relation.referenceMathias C, 2020, J THORAC ONCOL, V15, P170, DOI 10.1016/j.jtho.2019.07.028eng
hcfmusp.relation.referenceMazieres J, 2019, ANN ONCOL, V30, P1321, DOI 10.1093/annonc/mdz167eng
hcfmusp.relation.referenceMerker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671eng
hcfmusp.relation.referenceMok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7eng
hcfmusp.relation.referenceNeder L, 2019, PRECISION MED, V4, P1eng
hcfmusp.relation.referenceOxnard GR, 2020, ANN ONCOL, V31, P507, DOI 10.1016/j.annonc.2020.01.013eng
hcfmusp.relation.referencePalacio S, 2019, ONCOLOGIST, V24, pE137, DOI 10.1634/theoncologist.2018-0254eng
hcfmusp.relation.referencePassiglia F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30780-4eng
hcfmusp.relation.referencePinsolle J, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00233eng
hcfmusp.relation.referencePinto MT, 2015, CAD SAUDE PUBLICA, V31, DOI 10.1590/0102-311X00192013eng
hcfmusp.relation.referenceRolfo C, 2018, J THORAC ONCOL, V13, P1248, DOI 10.1016/j.jtho.2018.05.030eng
hcfmusp.relation.referenceRotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84eng
hcfmusp.relation.referenceSantos M, 2019, LANCET ONCOL, V20, P20, DOI 10.1016/S1470-2045(18)30822-2eng
hcfmusp.relation.referenceSchoenfeld AJ, 2019, ANN ONCOL, V30, P839, DOI 10.1093/annonc/mdz077eng
hcfmusp.relation.referenceSharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088eng
hcfmusp.relation.referenceSuh JH, 2016, ONCOLOGIST, V21, P684, DOI 10.1634/theoncologist.2016-0030eng
hcfmusp.relation.referenceThompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication.latestForDiscovery0df25c0f-1337-424e-b0f7-41d0fccb51fc
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_ARAUJO_Nextgeneration_sequencing_of_circulating_tumor_DNA_for_metastatic_2020.PDF
Tamanho:
1.39 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03